2-(3-methylpentyl)pyridine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-(3-methylpentyl)pyridine
• 英文别名: 2-(3-Methyl-pentyl)-pyridin
• 化学式: C₁₁H₁₇N
• 分子量: 163.263
• InChiKey: RKJVTLQKUKZDHS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.55
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 氢氧化钾 作用下， 生成 2-(3-methylpentyl)pyridine
  参考文献：
  名称：

  The Pyridylethylation of Active Nitrogen Compounds. II. Further Studies of the Reactions of 2-Vinylpyridine with Ketones

  摘要：

  DOI：

  10.1021/ja01102a030

文献信息

• Fe-Catalyzed Reductive Couplings of Terminal (Hetero)Aryl Alkenes and Alkyl Halides under Aqueous Micellar Conditions
  作者：Haobo Pang、Ye Wang、Fabrice Gallou、Bruce H. Lipshutz

  DOI：10.1021/jacs.9b04510

  日期：2019.10.30

  aromatic or heteroaromatic and an alkyl bromide or iodide leads, in the presence of Zn and a catalytic amount of an Fe(II) salt, to a net reductive coupling. The new C-C bond is regiospecifically formed at rt at the -site of the al-kene. The coupling only occurs in an aqueous micellar medium, where an atypical carbanionic, as opposed to radical, process is likely, supported by several control experiments

  在Zn和催化量的Fe(II)盐的存在下，乙烯基取代的芳族或杂芳族和烷基溴或碘的组合导致净还原偶联。新的 CC 键在 rt 在烯烃的  位点区域特异性地形成。偶联仅发生在水性胶束介质中，其中可能是非典型的碳负离子过程，而不是自由基过程，这得到了几个控制实验的支持。提出了一种基于这些数据的机制。
• Zn-promoted regio- and sequence-selective one-pot joining reactions of three components: vinylpyridines, alkyl iodides, and carbonyl compounds (or nitriles)
  作者：Kenji Mineyama、Hirofumi Maekawa、Akihiro Kohsaka、Yoshimasa Yamamoto、Ikuzo Nishiguchi

  DOI：10.1016/j.tet.2009.06.073

  日期：2009.9

  of alkyl iodides (3) into the solution containing 2-(or 4-)vinylpyridine (1 or 2) and carbonyl compounds (6) in the presence of Zn-powder (99.9%) in acetonitrile under refluxing brought about regio- and sequence-selective joining reaction of three components to give the corresponding (2-hydroxyethyl)pyridines (7 or 8) in good to moderate yields. On the other hand, 2-(2- or 4-pyridyl)ethyl alkyl ketones

  在锌粉（99.9％）存在下，在乙腈中回流下，将烷基碘化物（3）添加到含有2-（或4-）乙烯基吡啶（1或2）和羰基化合物（6）的溶液中，从而产生区域和三个组分的序列选择性连接反应以良好至中等的产率得到相应的（2-羟乙基）吡啶（7或8）。另一方面，通过将烷基碘（3）添加到2-（或4）的溶液中，通过三种组分的相似的连接反应，获得了2-（2-或4-吡啶基）乙基烷基酮（10或11）。-）乙烯基吡啶（1或2），以及在相似的反应条件下，含甲苯的锌粉（99.9％）中的腈（9）。
• Benzimidazole derivatives: preparation and pharmaceutical applications
  申请人：MEI PHARMA, INC.

  公开号：US10201527B2

  公开（公告）日：2019-02-12

  The present invention relates to hydroxamate compounds which are inhibitors of histone deacetylase. More particularly, the present invention relates to benzimidazole containing compounds and methods for their preparation. These compounds may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with dysregulation of histone deacetylase (HDAC).

  本发明涉及作为组蛋白去乙酰化酶抑制剂的羟酰胺化合物。更具体地说，本发明涉及含苯并咪唑的化合物及其制备方法。这些化合物可用作治疗增殖性疾病以及涉及组蛋白去乙酰化酶（HDAC）失调或与之有关的其他疾病的药物。
• PATTERN TREATMENT METHODS
  申请人：Rohm and Haas Electronic Materials LLC

  公开号：US20170170008A1

  公开（公告）日：2017-06-15

  Pattern treatment methods comprise: (a) providing a semiconductor substrate comprising a patterned feature on a surface thereof; (b) applying a pattern treatment composition to the patterned feature, wherein the pattern treatment composition comprises a polymer comprising a surface attachment group for forming a bond with a surface of the patterned feature and a solvent, and wherein the pattern treatment composition is free of crosslinkers; (c) removing residual pattern treatment composition from the substrate with a first rinse agent, leaving a coating of the polymer over and bonded to the surface of the patterned feature; and (d) rinsing the polymer-coated patterned feature with a second rinse agent that is different from the first rinse agent, wherein the polymer has a solubility that is greater in the first rinse agent than in the second rinse agent. The methods find particular applicability in the manufacture of semiconductor devices for providing high resolution patterns.
• BENZIMIDAZOLE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS
  申请人：MEI PHARMA, INC.

  公开号：US20170360757A1

  公开（公告）日：2017-12-21

  The present invention relates to hydroxamate compounds which are inhibitors of histone deacetylase. More particularly, the present invention relates to benzimidazole containing compounds and methods for their preparation. These compounds may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with dysregulation of histone deacetylase (HDAC).